Stiripentol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Stiripentol. Educational only — not medical advice.
Labeled uses
DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of DIACOMIT as monotherapy in Dravet syndrome.
Source: FDA labeling via NIH DailyMed (set 58304ba8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.